News Archives - Page 2 of 2 - IMPACT Partnership

IMPACT appoints Professor Ronjon Chakraverty as Medical Director

IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director.

COVID19_BMT Study Open

The IMPACT Clinical Trials Network is excited to collaborate with Dr Giovanna Lucchini at Great Ormond Street Hospital (GOSH) on a study of COVID19 infection in allogenic stem cell recipients

Call for New Clinical Trial Proposals

Call for proposals for innovative randomised clinical trials in allogeneic and autologous stem cell transplantation

Call for IMPACT Deputy Medical Director

Applications are now invited to the post of IMPACT Deputy Medical Director

BSBMT CTC – IMPACT meeting

30 delegates attended the 3rd BSBMT CTC – IMPACT meeting held in Birmingham to review new trial proposals for IMPACT.

BRITISH SCIENCE WEEK: BIRMINGHAM BECOMES NEW HUB OF LIFESAVING CLINICAL TRIALS

Birmingham is at the centre of a new £4million clinical trials network which will improve stem cell therapy for people across the UK, it has been announced this British Science Week.

REPORT: IMPACT LAUNCH

The UK’s first ever clinical trials partnership for stem cell transplantation was formally launched on 1 November.

VIDEO: A PATIENT’S PERSPECTIVE

Deborah Harkins, a Public Health Director from North Worcestershire, gives a patient’s perspective on the importance of clinical trials.

VIDEO: IMPACT LEADERS MEET FOR THE FIRST TIME

“We had a really good meeting” – Prof David Marks

PARTICIPATING TRANSPLANT CENTRES ANNOUNCED

Twenty-two transplant centres across the UK have been selected as participating centres in the IMPACT partnership

NEW CLINICAL TRIALS PARTNERSHIP AGREED

Four organisations have signed a collaboration agreement to create a new clinical trials platform that will accelerate treatments for stem cell transplant recipients.

PROF DAVID MARKS ANNOUNCED AS IMPACT MEDICAL DIRECTOR

Professor David Marks has been appointed Medical Director for the IMPACT clinical trials platform, a partnership between Anthony Nolan, Leuka, NHS Blood and Transplant, and the University of Birmingham.